Motoko Kimura

Title: Motoko Kimura: Innovator in Antibody Development

Introduction

Motoko Kimura is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her innovative work has led to the creation of a patent that holds promise for therapeutic applications.

Latest Patents

Motoko Kimura holds a patent for an anti-MYL9 antibody. This invention provides an anti-Myl9 antibody or a Myl9 binding fragment that binds to Myl9 and may inhibit the interaction between Myl9 and CD69 in humans. The patent also includes a pharmaceutical composition comprising this antibody. A mouse anti-human/mouse Myl9 monoclonal antibody with binding affinity against Myl9 was developed, and the sequence for the complementarity determining region (CDR) of this antibody was identified. Consequently, a humanized antibody incorporating the CDR sequence in the variable region of heavy and light chains was produced.

Career Highlights

Throughout her career, Motoko Kimura has worked with esteemed institutions, including Chiba University and Eisai R&D Management Co., Ltd. Her research has focused on advancing the understanding and application of antibodies in medical science.

Collaborations

Motoko has collaborated with notable colleagues such as Toshinori Nakayama and Koji Hayashizaki. These partnerships have contributed to her success in the field of antibody research.

Conclusion

Motoko Kimura's innovative work in developing the anti-MYL9 antibody showcases her dedication to advancing biotechnology. Her contributions have the potential to impact therapeutic strategies significantly.